A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults
Phase of Trial: Phase III
Latest Information Update: 30 Jan 2016
At a glance
- Drugs BLI 400 (Primary) ; Lubiprostone
- Indications Constipation
- Focus Registrational; Therapeutic Use
- Sponsors Braintree Laboratories
- 25 Jan 2016 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 03 Aug 2015 Status changed from recruiting to active, no longer recruiting as reported by Clinicaltrials.gov record.
- 02 Jul 2015 New trial record